The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors.

Edits on 26 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 26 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=1092022700

Edits on 17 May, 2023

"update inverses"

Golden AI

edited on 17 May, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11649459 Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases

Edits on 26 Apr, 2023

"Entity importer update"

Golden AI

edited on 26 Apr, 2023

Infobox

Is a

Patent

Patent Applicant

Voyager Therapeutics

Current Assignee

Voyager Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109202270

Date of Patent

February 16, 2021

Patent Application Number

167744930

Date Filed

January 28, 2020

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=109202270

Patent Citations

‌

US Patent 10041090 Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby

‌

US Patent 10047377 Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor

Patent Citations Received

‌

US Patent 11434502 Treatment of amyotrophic lateral sclerosis (ALS)

‌

US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

‌

US Patent 11603542 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

Patent Primary Examiner

‌

Ekaterina Poliakova-Georgantas

Edits on 1 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 1 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

"update citations for inverse infoboxes"

Golden AI

edited on 1 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11434502 Treatment of amyotrophic lateral sclerosis (ALS)

Edits on 15 Mar, 2023

"update inverses"

Golden AI

edited on 15 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11603542 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

Edits on 4 Jan, 2023

"update inverses"

Golden AI

edited on 4 Jan, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11542506 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

Edits on 6 Oct, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 6 Oct, 2022

Infobox

Patent Citations

‌

US Patent 10041090 Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby

Edits on 26 Sep, 2022

"Entity importer update"

Golden AI

edited on 26 Sep, 2022

Infobox

Is a

Patent

Patent Applicant

Voyager Therapeutics

Current Assignee

Voyager Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109202270

Date of Patent

February 16, 2021

Patent Application Number

167744930

Date Filed

January 28, 2020

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=109202270

Patent Citations

‌

US Patent 10041090 Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby

‌

US Patent 10047377 Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor

Patent Citations Received

‌

US Patent 11434502 Treatment of amyotrophic lateral sclerosis (ALS)

Patent Primary Examiner

‌

Ekaterina Poliakova-Georgantas

Edits on 7 Sep, 2022

"update inverses"

Golden AI

edited on 7 Sep, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11434502 Treatment of amyotrophic lateral sclerosis (ALS)

Edits on 18 Jun, 2022

"Entity importer update"

Golden AI

edited on 18 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=10920227

Edits on 10 Feb, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 10 Feb, 2022

Edits made to:

Infobox (+11 properties)

‌

US Patent 10920227 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

Infobox

Is a

Patent

Patent applicant

Voyager Therapeutics

Current assignee

Voyager Therapeutics

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10920227

Date of patent

February 16, 2021

Patent application number

16774493

Date Filed

January 28, 2020

Patent citations

‌

US Patent 10041090 Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby

‌

US Patent 10047377 Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor

Patent primary examiner

‌

Ekaterina Poliakova-Georgantas

Find more entities like US Patent 10920227 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.